RGD Reference Report - Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.

Authors: Drazen, JM  Yandava, CN  Dube, L  Szczerback, N  Hippensteel, R  Pillari, A  Israel, E  Schork, N  Silverman, ES  Katz, DA  Drajesk, J 
Citation: Drazen JM, etal., Nat Genet 1999 Jun;22(2):168-70.
RGD ID: 734557
Pubmed: PMID:10369259   (View Abstract at PubMed)
DOI: DOI:10.1038/9680   (Journal Full-text)

Clinically similar asthma patients may develop airway obstruction by different mechanisms. Asthma treatments that specifically interfere with the 5-lipoxygenase (ALOX5) pathway provide a method to identify those patients in whom the products of the ALOX5 pathway (that is, the leukotrienes) contribute to the expression of the asthma phenotype. Failure of an asthma patient to respond to treatment with ALOX5-pathway modifiers indicates that leukotrienes are not critical to the expression of the asthmatic phenotype in that patient. We previously defined a family of DNA sequence variants in the core promoter of the gene ALOX5 (on chromosome 10q11.2) associated with diminished promoter-reporter activity in tissue culture. Because expression of ALOX5 is in part transcriptionally regulated, we reasoned that patients with these sequence variants may have diminished gene transcription, and therefore decreased ALOX5 product production and a diminished clinical response to treatment with a drug targeting this pathway. Such an effect indicates an interaction between gene promoter sequence variants and drug-treatment responses, that is, a pharmacogenetic effect of a promoter sequence on treatment responses.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
asthma treatmentIAGP 734557 RGD 
asthma treatmentISOALOX5 (Homo sapiens)734557; 734557 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Alox5  (arachidonate 5-lipoxygenase)

Genes (Mus musculus)
Alox5  (arachidonate 5-lipoxygenase)

Genes (Homo sapiens)
ALOX5  (arachidonate 5-lipoxygenase)


Additional Information